ELSA AI pricing

Clear prices. Defined scope. Fixed fee before delivery starts.

The fee is on this page. You know what it costs before you call. Where scope determines the fee, we give you a range on the call and confirm the fixed fee in writing before any work starts.

The 20-minute scoping call

We use the call to establish whether ELSA AI is the right fit, identify the likely service route, and give you the applicable fee or an indicative range based on what you describe. We will tell you honestly if the engagement is not right for your situation. This is a scoping conversation, not a governance assessment.

Book a 20-minute discovery call

Discover + Evidence

Starting point

Clinical AI Exposure Diagnostic™

Standard Diagnostic

£5,500 + VAT

Evidence-ready to a board-ready evidence pack in four working days. Leadership readout follows at a mutually agreed time.

Identify and document the declared, staff-reported and evidence-supported AI use found within the agreed scope. It also records what patient data that use may touch, what evidence is missing and what should be prioritised in the next 30 days.

Diagnostic with Ambient Scribe Assessment Sheet

Clinical AI Exposure Diagnostic™ with Ambient Scribe Assessment Sheet

£8,500 + VAT

Delivered in six working days from the Evidence-Ready Start Date.

A separate six-working-day engagement. The ambient scribe assessment runs through the full evidence pack, not as a standalone addition.

The assessment examines: how the scribe is used in consultations and where it sits in the clinical workflow; what patient data, audio and transcripts it handles; how long recordings are retained, where they are stored, and whether they are used for model training; what the clinic's data protection position is and what supplier documentation it holds; what patients are told and how they can object; how clinicians review and approve AI-generated notes before they enter the record; and what clinical safety evidence is available for the clinic's DPO and Clinical Safety Officer to consider.

Each area receives an advisory evidence position, a RAG rating and a priority action. The assessment is not a product recommendation, a medical device classification, or a clinical safety sign-off.

Explore the Ambient Scribe Assessment

View the DiagnosticBook a call

Decide + Govern

Clinical AI Safe Usage Launchpad™

Scoped from your Diagnostic findings

Turn the findings into a board-ready governance baseline covering policy, registers, DPIA readiness, patient wording, staff guidance, human oversight and incident processes.

A fixed fee and timeline are confirmed in writing before you commit.

View the Launchpad

Maintain

AI Exposure Sentinel™

£950 per month, £2,850 per quarter in advance, or £10,500 per year prepaid, + VAT. Annual prepaid is preferred

Quarterly, on an annual agreement

Keep an established governance baseline current as tools, staff use, supplier terms and external questions change.

Sentinel maintains an established governance baseline. It follows a Launchpad. A baseline built elsewhere may be considered after a separately priced review confirming that it is complete enough to maintain.

View Sentinel

What the fee covers

The fee covers the leadership intake and interview, confidential role-level Staff AI Use Survey, evidence review, assessment of the agreed scope and the complete nine-part Diagnostic pack. The four-day delivery window begins only after the agreed intake, leadership interview and Staff AI Use Survey are complete, available evidence has been provided or confirmed unavailable, and ELSA AI has confirmed the Standard scope and delivery date in writing. Evidence-ready to a board-ready evidence pack in four working days. Leadership readout follows at a mutually agreed time.

  1. 1.

    AI Tool and Use Case Inventory

    A controlled inventory of the AI tools and use cases identified through leadership input, confidential staff reporting and submitted evidence.

  2. 2.

    Board Findings Report

    What was found and what it means, written for partners and boards rather than for specialists.

  3. 3.

    RAG Exposure Map

    Thirteen governance dimensions, rated, on one page.

  4. 4.

    Ambient Scribe Assessment Sheet

    Where a scribe, transcription or note-generation tool is in use, in trial or planned.

  5. 5.

    DPIA Readiness and Patient Data Exposure Note

    Written for your DPO.

  6. 6.

    Vendor Data Position and Evidence Tracker

    What each supplier has evidenced, and what is missing.

  7. 7.

    MDO, PMI and Insurer Disclosure Readiness Note

    What you can currently evidence if you are asked, and what you cannot.

  8. 8.

    30-Day Priority Action Plan

    Every finding converted into a dated action with a named owner.

  9. 9.

    Source and Guidance Mapping Appendix

    Every recommendation traced back to its source.

Also included

  • Confidential Staff AI Use Survey, reported at role level and never attributed to individuals.
  • Leadership interview and kickoff, completed before the Evidence-Ready Start Date.
  • A 60-minute remote leadership readout offered within 1–2 working days after pack delivery, at a mutually agreed time.

What four working days from the Evidence-Ready Start Date is scoped to

The Diagnostic is a defined piece of work. Its scope is measured before the Evidence-Ready Start Date, so you see the confirmed fee and delivery window before any work begins.

Standard Diagnostic scope envelope at £5,500 + VAT
ConditionIncluded at £5,500 + VAT
SitesOne
StaffUp to 60
AI tools or use casesUp to five
Suppliers requiring evidence reviewUp to five
Evidence documentsUp to 25
Clinical specialtiesOne
Ambient scribe, AI transcription or note-generation toolNone in use, in trial or planned
NHS contract or NHS data-sharing arrangementNone in scope

Scope beyond this is priced before work starts, never after. See "What costs more" below.

If an ambient scribe is in use, in trial or planned, the engagement uses the Clinical AI Exposure Diagnostic™ with Ambient Scribe Assessment Sheet at £8,500 + VAT, delivered in six working days.

A separate six-working-day engagement. The ambient scribe assessment runs through the full evidence pack, not as a standalone addition.

What costs more

Additional Diagnostic scope and fees
ScopeFee and timeline
Six to eight AI toolsScoped separately following intake.
Nine or more AI toolsScoped separately following intake.
Ambient scribe in use, trial or planned£8,500 + VATSix working daysScope variant: Clinical AI Exposure Diagnostic™ with Ambient Scribe Assessment Sheet at £8,500 + VAT, delivered in six working days. The standard £5,500 + VAT does not apply where a scribe is in scope.A separate six-working-day engagement. The ambient scribe assessment runs through the full evidence pack, not as a standalone addition.
Multi-site group, larger healthcare provider, mixed specialties or NHS contract in scopeScoped separately following intake.

How the fee is set

  1. 1

    On the discovery call

    You receive an indicative fee range based on your organisation’s profile and declared scope. A fixed fee is not quoted against a scope that has not yet been measured.

  2. 2

    Evidence-Ready Start Date

    The Evidence-Ready Start Date is the delivery commencement date confirmed by ELSA AI in writing after:

    • the engagement letter has been accepted
    • the initial payment requirement has been satisfied
    • the leadership intake and interview are complete
    • the Staff AI Use Survey has closed
    • available evidence has been submitted or formally confirmed unavailable
    • the Standard or Ambient Scribe route has been confirmed
    • the scope, fee and delivery date have been issued in writing

    The actual scope is measured: sites, staff, AI tools, suppliers, evidence volume, scribe status and regulatory footprint.

  3. 3

    Before work starts

    ELSA AI confirms the fixed fee, delivery period and delivery window in writing. Where the confirmed scope is larger than first discussed, your organisation can accept the revised position or withdraw with a full refund.

  4. 4

    From the Evidence-Ready Start Date

    The fee does not change.

If we find AI you did not know about

If additional AI use is discovered after delivery starts, every identified use will be recorded. Tools within the agreed depth limit will be assessed fully. Any additional tools will be triaged, registered and assigned a follow-up action. The agreed delivery date and fee will not change.

Why the Launchpad does not have a published number

A Launchpad is built from the Diagnostic findings. Until those findings exist, nobody knows how many AI tools need governing, how many workflows need a documented human-review step or how much of the governance baseline already exists.

Publishing a number and moving it once the scope became visible would not be transparent pricing.

The Launchpad is therefore scoped from the Diagnostic, quoted as a fixed fee with a fixed timeline, and confirmed in writing before your organisation commits. It is a substantial multiple of the Diagnostic fee, typically a five-figure commitment.

Remote, by design

Every ELSA AI engagement is delivered remotely: leadership interview, confidential staff survey, evidence review, deliverable pack and readout.

The Diagnostic assesses the evidence the organisation provides, staff-reported AI use and supplier documentation. It is not an inspection of premises or a verification of day-to-day operational practice.

Remote delivery also protects the confidentiality of the staff survey and avoids creating the impression that activities not raised during an onsite visit have been cleared.

Payment terms

1.Standard Diagnostic
50% on acceptance of the engagement letter and 50% on delivery
2.Prioritised Diagnostic against a dated external deadline
100% in advance. No urgency premium.
3.Launchpad
50% on signature, 25% at midpoint and 25% on final readout
4.Sentinel
Monthly in advance, quarterly in advance, or annually prepaid.

Invoices are payable within 14 days. All fees are exclusive of VAT.

What no fee buys

  • No legal advice or legal sign-off.
  • No CQC approval, ICO approval or NHS accreditation.
  • No insurer coverage or underwriting decision.
  • No MDO indemnity decision.
  • No completed or signed DPIA.
  • No clinical safety case sign-off.
  • No DCB0160 authorship.
  • No appointment as Clinical Safety Officer.
  • No medical device or SaMD classification decision.
  • No certification or guarantee of compliance.

Pricing FAQ

Start with a 20-minute discovery call

You will receive a direct view on fit, an indicative fee range and a clear explanation of what happens next. The fixed fee is confirmed in writing before the Evidence-Ready Start Date.

Book a 20-minute discovery callTry the Clinical AI Risk Check